The clinical management of a patient with systemic fungus infection is dependent upon so many different factors that no single form of therapy can be recommended for any one mycosis. Because of variations in response to different types of therapy, the clinical course must be the chief guide in the treatment of each patient. It is the purpose of this paper to present immunologic data obtained in a few cases of mycotic infection and to correlate these findings with the results of various therapeutic procedures.
The clinical management of a patient with systemic fungus infection is dependent upon so many different factors that no single form of therapy can be recommended for any one mycosis. Because of variations in response to different types of therapy, the clinical course must be the chief guide in the treatment of each patient. It is the purpose of this paper to present immunologic data obtained in a few cases of mycotic infection and to correlate these findings with the results of various therapeutic procedures.
It should be emphasized that there are certain fundamental differences between the reaction of the animal tissues to invasion by fungi and that produced by viruses or bacteria. Bacteria and viruses are small-sized and often toxic, frequently causing acute and severe pathologic changes to which the infected animal usually responds with the formation of large amounts of easily detectable antibodies. In contrast, the fungi are larger, much less toxic and the animal usually responds sluggishly to the infection. The fungi multiply more slowly in the tissues, and being less antigenic, they do not stimulate the tissues of the infected animal to rapid antibody formation. Furthermore, because of the more complex morphology of the fungi in culture, it is more difficult to prepare smooth, particulate suspensions for use as antigens in serologic tests. These suspensions, because of surfacemass relationships, are less sensitive than the ordinary bacterial antigens.
The comparatively slow progress of most fungus infections allows ample time for the tissues to become hypersensitive to the fungus or fungus products. Although a negative reaction to Blastomyces dermatitidis does not exclude the possibility of the presence of blastomycosis, a positive reaction is diagnostic of the disease and we have not as yet obtained a positive reaction in patients with other diseases. In contrast, a skin reaction to a Gandida (Monilia) vaccine is common in patients who do not have moniliasis, due presumably to the frequent occurrence of these fungi in normal patients as well as those suffering from other diseases.
In the table are listed the serologic findings and the skin reactions in 17 cases of American blastomycosis (Gilchrist's disease). The case labeled "S. C." was not seen in this clinic but the serum and pus from a subcutaneous abscess were sent to us through the courtesy of Dr. William H. Kelley of Charleston, S. C. The diagnosis in every case was confirmed by culture. The techniques used in performing the complement fixation and skin tests have been described before (1) , except that in some instances both tests were done with a saline extract of Blastomyces prepared by grinding the frozen and dried fungi in a ball mill. Patients with Gilchrist's disease may be divided into 4 clear-cut groups by classifying them as to their degree of allergy and titer of comple-. ment fixing antibodies.
We have placed 6 patients in group 1, all of whom had a high titer of complement fixing antibodies but gave a negative or weak skin reaction to the intradermal injection of vaccine. The South Carolina patient was not skin tested, and we have no details conceruing the extent of his disease, other than that he was discharged from the hospital with a hopeless prognosis. Four of the patients in this group died with generalized disease and the necropsy findings have been described elsewhere (2) . One patient (W. M.) had blastomycotic lesions on the bridge of his nose, the right shoulder, and on the large toe of his right foot.
Although he had no pulmonary symptoms, roentgenographic study showed a diffuse soft infiltration throughout the upper twothirds of both lungs. The x-ray pictures were studied by Dr.
William Wallace, who felt that the lesion resembled fungus infection rather than tuberculosis because of the absence of cavitation. Although we could obtain no sputum for examination,the suggested that the infection was deep-seated and that the lungs probably were involved. This patient remained in the hospital for only a short time and we have no record of his present condition, but a recent letter from his physician states that the patient had developed a freely movable abdominal mass in the region of his umbilicus.
In group 2 are listed 3 patients who showed some degree of hypersensitiveness to Blastomyces and who also had some complement fixing antibodies, as shown by serologic examination. The patient with the highest titer (V. S.) was remarkable in that she had extensive lesions involving the lungs, peritoneum, uterus, Fallopian tubes and vertebrae. She is classified as cured because she has had no recurrence of the disease 7 years since the onset of symptoms. Her complement fixation reaction has been negative since December 1935. This patient was treated with iodides after a preliminary period of desensitization by small doses of Blastomyces vaccine. The uterus and both tubes were removed later (3). The other two patients in this group improved with vaccine and iodide treatment.
In group 3 are included 5 patients who had no detectable complement fixing antibodies in their serum but who were definitely allergic to the fungus. All of these patients improved markedly after vaccine treatment followed by iodides or x-ray. One patient (H. L.) illustrated beautifully the dangers of iodide therapy in a patient who is allergic to the fungus. This man developed fever and the lesion spread violently during the time that iodides were given; recovery followed the withdrawal of iodides and the administration of minute doses of vaccine. Vaccine treatment was continued for a long time before the patient was able to take iodides without symptoms referable to the local lesion (4). Another patient (N. A.) was discharged greatly improved and was not seen again until April 18, 1941, 4 years after his discharge from the hospital. He had taken no medicine or treatment of any kind and his lesions had all recurred. Skin test at this time showed only a 1+ reaction and his complement fixation test was still negative.
Group 4 comprises 3 patients who gave a negative reaction to both tests. One remained in the hospital for only two weeks and the outcome could not be determined. Another patient (G. J.) with very extensive blastomycosis of the skin, involving the face and all extremities, gave a negative skin test and a negative complement fixation reaction. His lungs were not involved.
As he died at home 4 years after the onset of his illness, we have no information concerning the lesions at the time of death. The third patient in this group (H. M.) had two bone lesions and was of exceptional interest in that his recovery followed administration of small amounts of serum. He presented an unusual immunologic picture in that the skin test was negative despite the fact that he had had his disease long enough to have developed an allergic reaction to the fungus. The patient did not present the clinical picture of an overwhelming infection, and this view was strengthened by the lack of detectable complement fixing antibodies in his serum. Since this patient showed no sensitivity to vaccine, iodides were given, but the infection in the bone of his elbow continued to progress and it was felt that an amputation of the arm would be necessary. At this time the patient was tested with an anti-Blastomyces rabbit serum which caused the formation of an immediate erythematous reaction (Foshay test).
The normal rabbit serum control caused no reaction. Small increasing doses of rabbit serum were then given and the lesion began to heal. Maggots were used to help clean away the dead tissue and improve drainage. Following serum treatment, the immunologic picture was reversed; the previously negative skin test to vaccine became positive and, for a short time, complement fixing antibodies appeared in the blood, but to a maximum titer of only 1-2. This case record has been published elsewhere (5) but is included here to emphasize the possibility of serum treatment in cases showing this unusual immunologic picture.
We realize that it is dangerous to draw conclusions from this small series of cases, but it is very doubtful if even a much larger series would yield data sufficiently accurate for statistical analysis, because of the great variations in the clinical picture, in the duration of the disease and in the reaction of the host to his infection.
The patients in this series had many forms of therapy including a good diet, vitamins, potassium iodide, ethyl iodide inhalations, local applications of tincture of iodine, local applications of copper sulphate by compress and iontophoresis and varying amounts of x-ray therapy in addition to surgical intervention in several cases. However, we feel justified in concluding that the titer of complement fixing antibodies reflects, within limits, the degree of involvement of the patient's tissues. The complement fixing titer of patients with generalized disease is high and remains high until death, but widespread skin infections may exist without sufficient antibody formation to be detected by the relatively insensitive antigen used in the test. Conversely, a low or negative antibody titer suggests that involvement of the internal organs is not widespread. A fall in antibody titer suggests that the patient is improving, as noticed in case V. S., and also in a case of chromoblastomycosis seen by us in which the titer of complement fixing antibodies in the patient's serum decreased as the clinical lesions improved (6).
We believe that the degree of allergy should be determined before outlining the course of treatment and that no iodide or x-ray therapy should be started without preliminary partial desensitization of the patient. In cases giving a negative reaction to both tests, the prognosis is doubtful. Only two of our 3 patients with these immunologic findings were followed and in neither of these were iodides of any benefit, yet in one case serum therapy seemed to initiate recovery. The other patient was seen before we had prepared an antiserum. of 17 (82 per cent) reacted to one or the other test, or both. Blastomycosis, therefore, cannot be excluded by negative reactions to both tests. However, in patients with evidences of severe systemic infection such as multiple abscesses and severe pulmonary or bone lesions of unknown etiology, it is felt that a negative complement fixation is of definite value in excluding blastomycotic infection.
The diagnosis of moniliasis is much more difficult to establish than blastomycosis because of the high incidence of Candida (Monilia) albicans in the vagina, sputum or feces of normal individuals or patients obviously not suffering with moniliasis.
Reactions to Monilia vaccines or extracts have little significance
because of the frequency of skin reactions in patients not suffering from the infection. Todd (7) has reported that the sera of 22.5 per cent of 1150 normal persons agglutinated Monilia albicans but of these oniy 35 (3 per cent) gave titers of 1-160 or more. In our experience agglutination tests have been disappointing as a method of diagnosis. Sharp agglutinin reactions with these large cell suspensions are very difficult to read and the clumps can be broken up easily by vigorous shaking. Moreover, we have tested some sera from clear-cut cases of pulmonary moniliasis in which agglutinins could not be satisfactorily demonstrated.
Because of these difficulties, the diagnosis of pulmonary moniiasis must depend upon the clinical picture, the constant presence of large numbers of yeastlike organisms in specimens of sputum, and the absence of other organisms known to cause chronic lung diseases, i.e. tuberculosis, lung abscess, bronchiectasis, infection with staphylococci or Friedlander's bacilli, etc.
Yeastlike organisms are found so frequently in chronic pulmonary infections of bacterial origin that some observers consider the fungus to be a secondary invader. We believe, however, that these organisms are important in the production of symptoms and the maintenance of infection, regardless of whether or not they represent the primary etiologic factor of the disease. A positive skin test to C. albicans is significant in a patient with pulmonary infection who has C. albicans constantly present in his sputum. A positive skin test in a patient without disease has no significance whatever.
One patient, a doctor's wife, was sent to us by Dr. Ezra Bridge of lola Sanatorium, Rochester, N. Y. She had been well until October 1933 when she had a coryza followed by a dry cough which persisted until December of the same year, when the cough became severe and she began to raise about 1 oz. of yellow sputum daily. She lost weight, strength and had some dyspnoea on exertion. Râles were heard in her chest and the x-ray showed a picture resembling mycotic infection rather than tuberculosis. She had had more than 50 sputum examinations, all of which were negative for tubercie bacilli, but C. albicans was isolated in T. Smith. Agglutination tests were negative but she gave a 3+ reaction to the intracutaneous injection of vaccine and was given a series of desensitizing doses of vaccine with rapid improvement. She has remained completely well for the past ft years, except for an occasional "cold" and sinusitis. Her husband reports that he gives her some vaccine following each cold as it seems to aid in clearing up the cough. In contrast to this immunologic picture of hypersensitivity to the fungus, patients may be encountered who give no reaction to the intracutaneous injection of vaccine. We have had the opportunity of studying a patient with pulmonary moniliasis who was under the care of Dr. E. L. Persons, Duke Hospital. The patient was extremely hypersensitive to iodides and was treated with intravenous injections of large amounts of gentian violet. The patient failed to improve clinically, lost weight and the roentgenologic examination showed spreading of the disease process. A Foshay test was positive and anti-C. albicans rabbit serum was administered. Within a month the patient's lungs had cleared completely and when seen on April 21, 1941, 6 months after her discharge from the hospital, she was entirely well, having gained 18.0 kilos (39.6 lbs.) since the time of her lowest weight 7 months before. Her immunologic picture was reversed following serum treatment; the agglutination test became positive and the intracutaneous injection of vaccine caused a small reaction.
SUMMARY
From a study of a limited number of deep-seated fungus infections we have found that the results of serologic examination are extremely helpful in outlining the course of treatment. A patient who is hypersensitive to the fungus must be partially desensitized before any other form of treatment, such as iodides or x-ray therapy, is instituted. Even simple surgical procedures, such as drainage of subcutaneous abscesses, are best deferred since in our experience draining sinuses are less likely to form if the patient has had vaccine treatment. If the patient is not hypersensitive to the fungus, lodides, gentian violet, x-ray therapy etc., may be instituted. However, these measures must be initiated cautiously as our knowledge of the disease process is far from complete. Occasionally a patient may be benefited by serum therapy. Serologic tests are of value in certain patients in establishing a diagnosis and are frequently helpful, especially in blastomycosis, in determining the extent of the disease and the prognosis. In the first place, as regards the use of iodides in our cases: the patients, without exception, had an unusual sensitivity to iodides. I do not know whether the iodides were actually producing iododermas in these cases, because all the patients had skin lesions which flared up so badly that we had to abandon the use of iodides.
These patients would get lymph node swellings from the iodides as well. We attempted to desensitize all our cases of systemic moniliasis with repeated small injections of oidiomycin or monilia extracts, without any beneficial therapeutic results. All other methods of treatment were ineffectual. All the four cases I have in mind were really very distressing and desperate. Of these, two died of internal moniliasis and one gradually got kidney involvement, and the fourth was lost track of. So that, if Dr. Martin's serum is going to be of value in these cases it must be welcomed as meeting a great need.
Dn. NELSON PAUL ANDERSON, Los Angeles: Dr. Hopkins said he did not feel capable of adding anything; and I feel the same way. I simply wish to speak of two different types of fungus infections which have responded to this line of therapy. In the southern part of California coccidiodes has a high mortality rate.
Dr. H. P. Jacobson, of Los Angeles, has been very much interested in this disease for a number of years. He has been treating such cases with vaccine, and he is able to show results that I have never seen duplicated. I do not say that he has cured these patients, but I have seen patients with 10, 15 or 20 draining sinuses from eoccidiodes who appeared to be in the last stages of the disease, in whom the disease has been arrested. I have seen these people back at work years later. The second point I wish to make is that there has been a similar occurrence in aetinomycosis. I have seen instances, particularly aetinomycosis of the liver, operated on under the mistaken diagnosis of liver abscess, and subsequent permanent fistula present. The disease was progressing unfavorably until the application of vaccine therapy, after which it seemed to respond. All these eases had failed to respond to iodides; and there was dramatic response to vaccine therapy. I think Dr. Martin is to be congratulated upon really bringing forth a therapeutic advance in the treatment of a very serious, and very frequently, fatal fungus infection.
DR. FRED WEIDMAN, Philedelphia: I do not know when there has been presented such a graphic presentation-one so clear-cut as this. The author began by intimating that, by and large, not as much is to be expected in the way of antigenie responses of practical value in the field of fungi as compared to the realm of the bacteria. This is true. For a long time we have had available in mycology only one such procedure of any value, and that is the agglutination test for sporotrichosis.
Dr. Martin's success, based on the fact that he has had 17 cases to work with, is indeed unusual. Then he had the ingenuity to make deductions which have resulted in the successes he has shown here. I mean this to be complimentary, and I am sure I voice the opinion of everybody.
I wish to know more about the preparation of the antiserum. I suppose that he has been using cultures grown on blood agar at incubator temperature from forms of fungus comparable to the tissue forms, and not from the forms developed in the culture tubes? DR. DONALD S. MARTIN, Durham, N. C.: I had hoped that there would not be too much discussion about the antiserum which is simply an anti-Blastomyces rabbit serum kept for diagnostic purposes. It is not necessary to isolate a patient with blastomycosis because of the very slight chance of transmission of the disease to a normal healthy individual which means that the normal body defense mechanisms are fairly adequate. In California Valley fever the patient takes care of the primary fungus infection himself, the progressively fatal disease representing a secondary infection with the same fungus. It is hard to avoid the feeling that some untreated cases of blastomycosis would recover if they had not been diagnosed and then given iodides. Iodide treatment in the allergic patient (and not all patients are allergic) may result in extension of the disease. We lost 3 patients in this manner. The first patient was given iodides and died promptly; another man who had been in the stationary stage for four years died six weeks after administration of the drug. We then tried vaccine treatment but only if the patient was sensitive as shown by skin testing with vaccine. The serum was used in only one patient because this patient was not allergic to the vaccine but did react positively to the "Foshay test." Anti-Monilia serum was made in the same way as the anti-Blastomyces serum and was used in the only Monilia case we have had who was not sensitive to Monilia vaccine. That this serum might have any effect on the course of the disease was considered because this patient had a positive "Foshay test" as shown by injection of the anti-Monilia serum.
All of our patients have had extensive forms of treatment such as good diet, bed rest, fluids, iodides, iontophoresis and x-rays. The most important thing in managing a patient with blastomycosis is for the physician to keep in close contact with the disease and try these forms of therapy as they are indicated by the progress of the infection and the serologic and sensitivity tests.
